Tenax Therapeutics (TENX) Other Working Capital Changes (2019 - 2022)
Tenax Therapeutics (TENX) reported Other Working Capital Changes of -$31152.0 for Q4 2022, down 24.08% on a YoY basis from -$41031.0 in Q4 2021, and down 2.02% sequentially from -$30535.0 in Q3 2022.
Tenax Therapeutics (TENX) Other Working Capital Changes (2019 - 2022) Analysis & Trends
Tenax Therapeutics (TENX) has 4 years of Other Working Capital Changes data on file, last reported at -$31152.0 in Q4 2022.
- For the quarter ending Q4 2022, Other Working Capital Changes fell 24.08% year-over-year to -$31152.0; the trailing twelve-month figure through Dec 2023 stood at -$61687.0 (up 48.33% YoY), and the FY2022 full-year result was -$119393.0, down 177.66% from the prior year.
- Other Working Capital Changes slipped to -$31152.0 in Q4 2022, from -$30535.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.2 million in Q4 2025 to a low of -$2.2 million in Q1 2026.
- A 5-year average of $203581.7 and a median of $35003.0 in 2022 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 121.86% in 2021 and plunged 533.65% in 2022, its largest moves.
- Tracing TENX's Other Working Capital Changes over 4 years: stood at -$25870.0 in 2019, then decreased by 18.84% to -$30743.0 in 2020, then grew by 18.33% to -$25107.0 in 2021, then dropped by 24.08% to -$31152.0 in 2022.
- Business Quant data shows TENX's Other Working Capital Changes at -$31152.0 in Q4 2022, -$30535.0 in Q3 2022, and -$29141.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -31,152.00 |
| Dec 31, 2022 | -31,152.00 |
| Dec 31, 2022 | -31,152.00 |
| Sep 30, 2022 | -30,535.00 |
| Sep 30, 2022 | -30,535.00 |
| Sep 30, 2022 | -30,535.00 |
| Jun 30, 2022 | -29,141.00 |
| Jun 30, 2022 | -29,141.00 |
| Jun 30, 2022 | -29,141.00 |
| Mar 31, 2022 | -28,565.00 |
| Mar 31, 2022 | -28,565.00 |
| Mar 31, 2022 | -28,565.00 |
| Dec 31, 2021 | -25,107.00 |
| Dec 31, 2021 | -25,107.00 |
| Dec 31, 2021 | -25,107.00 |
| Sep 30, 2021 | -24,612.00 |
| Sep 30, 2021 | -24,612.00 |
| Sep 30, 2021 | -24,612.00 |
| Jun 30, 2021 | 6,720.00 |
| Jun 30, 2021 | 6,720.00 |